The committee identified several obstacles faced by civilian biodefense research workers that prevented ready access to SIP vaccines. Paramount among these are cost and travel.

Recommendation 8: All biodefense contracting and granting agencies should consider covering the cost of immunizing at-risk research workers, so that this cost is not borne solely by the institutions working on government-supported programs. The committee supports the idea of central SIP administration but recommends that the SIP explore options for having a small number of satellite clinic locations around the country to reduce travel and inconvenience for other participating institutions (provided that they are able to adhere to the IND protocols).

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement